Lignans and other co-passengers

Dietary Fibre Components and Functions

Volumn , Issue , 2007, Pages 199-218

  Adlercreutz, H ^a   Penalvo, J ^a   Heinonen, S M ^a   Linko Parvinen, A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alkylresorcinol; Cancer; Coronary heart disease; Human; Lignan

Indexed keywords

EID: 84886812423     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3920/978-90-8686-622-9     Document Type: Chapter

References (111)

1. Adlercreutz, H., T. Fotsis, R. Heikkinen, J.T. Dwyer, B.R. Goldin, S.L. Gorbach, A.M. Lawson and K.D.R. Setchell, 1981. Diet and urinary excretion of lignans in female subjects. Med. Biol. 59, 259-261.
2. Adlercreutz, H., T. Fotsis, R. Heikkinen, J.T. Dwyer, M. Woods, B.R. Goldin and S.L. Gorbach, 1982. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian women and in women with breast cancer. Lancet 2, 1295-1299.
3. Adlercreutz, H., T. Fotsis, C. Bannwart, K. Wähälä, T. Mäkelä, G. Brunow and T. Hase, 1986. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J. Steroid Biochem. 25, 791-797.
4. Adlercreutz, H., K. Höckerstedt, C. Bannwart, S. Bloigu, E. Hämäläinen, T. Fotsis and A. Ollus, 1987. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens, and on sex hormone binding globulin (SHBG). J Steroid Biochem, 27, 1135-1144.
5. Adlercreutz, H., K. Höckerstedt, C. Bannwart, E. Hämäläinen, T. Fotsis and S. Bloigu, 1988. Association between dietary fiber, urinary excretion of lignans and isoflavonic phytoestrogens, and plasma non-protein bound sex hormones in relation to breast cancer. In: F. Bresciani, R.J.B. King, M.E. Lippman and J.-P. Raynaud (eds.) Progress in Cancer Research and Therapy, Vol. 35: Hormones and Cancer 3. New York. Raven Press, pp. 409-412.
6. Adlercreutz, H., G.J. Wang, O. Lapcík, R. Hampl, K. Wähälä, T. Mäkelä, K. Lusa, M. Talme and H. Mikola, 1998. Time-resolved fluoroimmunoassay for plasma enterolactone. Anal. Biochem. 265, 208-215.
7. Adlercreutz, H., P. Bartels, V.-V. Elomaa and C. Kang, 2000. Phytoestrogens and prostate cancer. In: K. Descheemaker and I. Debruyne (eds.) Soy & Health 2000. Clinical evidence - Dietetic applications. Leuven/Apeldoorn. Garant, pp. 61-71.
8. Axelson, M., J. Sjövall, B.E. Gustafsson and K.D.R. Setchell, 1982. Origin of lignans in mammals and identification of a precursor from plants. Nature 298, 659-660.
9. Begum, A.N., C. Nicolle, I. Mila, C. Lapierre, K. Nagano, K. Fukushima, S.M. Heinonen, H. Adlercreutz, C. Remesy and A. Scalbert 2004. Dietary lignins are precursors of mammalian lignans in rats. J. Nutr. 134, 120-127.
10. Boccardo, F., G. Lunardi, P. Guglielmini, M. Parodi, R. Murialdo, G. Schettini and A. Rubagotti, 2004. Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur. J. Cancer 40, 84-89.
11. Boccardo, F., G.L. Lunardi, A.R. Petti and A. Rubagotti, 2003. Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk. Breast Cancer Res. Treat. 79, 17-23.
12. Burkitt, D.P., 1978. Colonic-rectal cancer: fiber and other dietary factors. Am. J. Clin. Nutr. 31, S58-S64.
13. Bylund, A., J.X. Zhang, A. Bergh, J.E. Damber, A. Widmark, A. Johansson, H. Adlercreutz, P. Åman, M.J. Shepherd and G. Hallmans, 2000. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 42, 304-314.
14. Bylund, A., E. Lundin, J.X. Zhang, A. Nordin, R. Kaaks, U.-H. Stenman, P. Åman, H. Adlercreutz, T.K. Nilsson, G. Hallmans, A. Bergh and P. Stattin, 2003. Randomized controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur. J. Cancer Prev. 12, 407-415.
15. Chen, Y., A.B. Ross, P. Åman and A. Kamal-Eldin, 2004. Alkylresorcinols as markers of wholegrain wheat and rye in cereal products. J. Agric. Food Chem. 52, 8242-8246.
16. Clavel, T., G. Henderson, C.A. Alpert, C. Philippe, L. Rigottier-Gois, J. Dore and M. Blaut, 2005. Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl. Environ. Microbiol. 71, 6077-6085.
17. Clavel, T., G. Henderson, W. Engst, J. Dore and M. Blaut, 2006. Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol. Ecol. 55, 471-478.
18. Davies, M.J., E.A. Bowey, H. Adlercreutz, I.R. Rowland and P.C. Rumsby, 1999. Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethanetreated rats. Carcinogenesis 20, 927-931.
19. Den Tonkelaar, I., L. Keinan-Boker, P. Van't Veer, C.J.M. Arts, H. Adlercreutz, J.H.H. Thijssen, P.H.M. Peeters, 2001. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 223-228.
20. Demark-Wahnefried, W., D.T. Price, T.J. Polascik, C.N. Robertson, E.E. Anderson, D.F. Paulson, P.J. Walther, M. Gannon and R.T. Vollmer, 2001. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery:exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58, 47-52.
21. Etminan, M., B. Takkouche and F. CaamanoIsorna, 2004. The role of tomato products and lycopene in the prevention of prostate cancer: A meta-analysis of observational studies. Cancer Epidem. Biomarker Prev. 13, 340-345.
22. Gubernator, J., M. Stasiuk and A. Kozubek, 1999. Dual effect of alkylresorcinols, natural amphiphilic compounds, upon liposomal permeability. Bba Biomembranes 1418, 253-260.
23. Hallmans, G., J.-X. Zhang, E. Lundin, A. Bergh, A. Sylvan, A. Bylund, A. Widmark, P. Stattin, J.-E. Damber, P. Åman, A. Johansson and H. Adlercreutz, 1999. Metabolism of lignans and their relation to prostate cancer. In International Conference on Diet and Prevention of Cancer with special emphasis on chemoprevention of cancer p. S8.34. Multiprint, Helsinki: Tampere, Finland.
24. Hebert, J.R., T.G. Hurley, B.C. Olendzki, J. Teas, Y. Ma and J.S. Hampl, 1998. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl. Cancer Inst. 90, 1637-1647.
25. Hedelin, M., Å. Klint, E.T. Chang, R. Belloco, J.-E. Johansson, S.-O. Andersson, S.-M.Heinonen, H. Adlercreutz, H.-O. Adami, H. Grönberg and K. Augustsson Bälter, 2006. Dietary phytoestrogens, serum enterolactone and risk of prostate cancer: the Cancer Prostate Sweden Study (Sweden). Cancer Causes Control 17, 169-180.
26. Heinonen, S., T. Nurmi, K. Liukkonen, K. Poutanen, B. Rafaelli, K. Wähälä, T. Deyama, S. Nishibe and H. Adlercreutz, 2001. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J. Agric. Food Chem. 49, 3178-3186.
27. Hirose, M., T. Yamaguchi, C. Lin, N. Kimoto, M. Futakuchi, T. Kono, S. Nishibe and T. Shirai, 2000. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett. 155, 79-88.
28. Horn-Ross, P.L., K.J. Hoggatt, D.W. West, M.R. Krone, S.L. Stewart, H. Anton, C.L. Bernstein, D. Deapen, D. Peel, R. Pinder, P. Reynolds, R.K. Ross, W. Wright and A. Ziogas, 2002 Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control, 13, 407-415.
29. Horn-Ross, P.L., E.M. John, M. Lee, S.L. Stewart, J. Koo, L.C. Sakoda, A.G. Shiau, J. Goldstein, P. Davis and E.J. Perez-Stable, 2001. Phytoestrogen consumption and breast cancer risk in a multiethnic population - The Bay Area Breast Cancer Study. Am. J. Epidemiol. 154, 434-441.
30. Horner, N.K., A.R. Kristal, J. Prunty, H.E. Skor, J.D. Potter and J.W. Lampe, 2002. Dietary determinants of plasma enterolactone. Cancer Epidem Biomarker Prev, 11 121-126.
31. Hultén, K., A. Winkvist, P. Lenner, R. Johansson, H. Adlercreutz and G. Hallmans 2002. An incident case-referent study on the lignan enterolactone and breast cancer. Eur. J. Nutr. 41, 168-176.
32. Ingram, D., K. Sanders, M. Kolybaba and D. Lopez, 1997. Case-control study of phytooestrogens and breast cancer. Lancet 350, 990-994.
33. Jacobs, D.R., Jr., K.A. Meyer, L.H. Kushi and A.R. Folsom, 1998. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am. J. Clin. Nutr. 68, 248-257.
34. Kamal-Eldin, A., A. Pouru, C. Eliasson and P. Åman, 2000. Alkylresorcinols as antioxidants:hydrogen donation and peroxyl radical-scavenging effects. J. Sci. Food Agric. 81, 353-356.
35. Keinan-Boker, L., Y.T. van der Schouw, D.E. Grobbee and P.H. Peeters, 2004. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr. 79, 282-288.
36. Key, T.J., N. Allen, P. Appleby, K. Overvad, A. Tjonneland, A. Miller, H. Boeing, D. Karalis, T. Psaltopoulou, F. Berrino, D. Palli, S. Panico, R. Tumino, P. Vineis, H.B. Buenode-Mesquita, L. Kiemeney, P.H.M. Peeters, C. Martinez, M. Dorronsoro, C.A. Gonzalez, M.D. Chirlaque, J.R. Quiros, E. Ardanaz, G. Berglund, L. Egevad, G. Hallmans, P. Stattin, S. Bingham, N. Day, P. Gann, R. Kaaks, P. Ferrari and E. Riboli, 2004. Fruits and vegetables and prostate cancer: No association among 1,104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 109, 119-124.
37. Khaw, K.T. and E. Barrett-Connor, 1987. Dietary fiber and reduced ischemic heart disease mortality rates in mrn and women; a 12-year prospective study. Am. J. Epidemiol. 126, 1093-1102.
38. Kilkkinen, A., K. Stumpf, P. Pietinen, L.M. Valsta, H. Tapanainen and H. Adlercreutz, 2001. Determinants of serum enterolactone concentration. Am. J. Clin. Nutr. 73, 1094-1100.
39. Kilkkinen, A., P. Pietinen, T. Klaukka, J. Virtamo, P. Korhonen and H. Adlercreutz, 2002. Use of oral antimicrobials decreases serum enterolactone concentration. Am. J. Epidem. 155, 472-477.
40. Kilkkinen, A., L.M. Valsta, J. Virtamo, K. Stumpf, H. Adlercreutz and P. Pietinen, 2003a. Intake of lignans is associated with serum enterolactone concentration in Finnish men and women. J. Nutr, 133, 1830-1833.
41. Kilkkinen, A., J. Virtamo, M.J. Virtanen, H. Adlercreutz, D. Albanes and P. Pietinen, 2003b. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidem. Biomark. Prev. 12, 1209-1212.
42. Kilkkinen, A., J. Virtamo, E. Vartiamen, R. Sankila, M.J. Virtanen, H. Adlercreutz and P. Pietinen, 2004. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int. J. Cancer 108, 277-280.
43. Kilkkinen, A., I. Erlund, M.J. Virtanen, G. Alfthan, K. Ariniemi and J. Virtamo 2006. Serum enterolactone concentration and risk of coronary heart disease in a case-control study of Finnish male smokers. Am. J. Epidem. 163, 687-693.
44. Kozubek, A., 1987a. The effect of 5-(n-alk(en)yl)resorcinols on membranes. I. Characterization of the permeability increase induced by 5-(n-heptadecenyl)resorcinol. Acta Biochim. Pol. 34, 357-367.
45. Kozubek, A., 1987b. The effect of 5-(n-alk(en)yl)resorcinols on membranes. II. Dependence of the aliphatic chain length and unsaturation. Acta Biochim. Pol. 34, 387-394.
46. Kozubek, A. and R.A. Demel, 1980. Permeability changes of erythrocytes and liposomes by 5-(n-alk(en)yl) resorcinols from rye. Biochim. Biophys. Acta, 603, 220-227.
47. Kozubek, A. and B. Nienartowicz, 1995. Cereal grain resorcinolic lipids inhibit H2O2-induced peroxidation of biological membranes. Acta Biochim. Pol. 42, 309-315.
48. Kozubek, A. and J.H.P. Tyman, 1995. Cereal grain resorcinolic lipids: mono- and dienoic homologues are present in rye grains. Chemistry Physics Lipids 78, 29-35.
49. Kuijsten, A., I.C.W. Arts, P.C.H. Hollman, P. van't Veer and E. Kampman, 2006. Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidem. Biomark. Prev. 15, 1132-1136.
50. Lampe, J.W., D.R. Gustafson, A.M. Hutchins, M.C. Martini, S. Li, K. Wähälä, G.A. Grandits, J.D. Potter and J.L. Slavin, 1999. Urinary isoflavonoid and lignan excretion on a Western diet: Relation to soy, vegetable, and fruit intake. Cancer Epidem. Biomark. Prev 8, 699-707.
51. Landström, M., J.X. Zhang, G. Hallmans, P. Aman, A. Bergh, J.-E. Damber, W. Mazur, K. Wähälä and H. Adlercreutz, 1998. Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 36 151-161.
52. Lichtenstein, P., N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe and K. Hemminki, 2000. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78-85.
53. Lin, X., B.R. Switzer and W. Demark-Wahnefried, 2001. Effect of mammalian lignans on the growth of prostate cancer cell lines. Anticancer Res. 21, 3995-3999.
54. Lin, X., J.R. Gingrich, W. Bao, J. Li, Z.A. Haroon and W.Demark-Wahnefried, 2002. Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology 60, 919-924.
55. Linko, A.M., K. Parikka, K. Wähälä and H. Adlercreutz, 2002. Gas chromatographic-mass spectrometric method for the determination of alkylresorcinols in human plasma. Anal. Biochem. 308, 307-313.
56. Linko, A. and H. Adlercreutz, 2004. Whole-grain rye and wheat alkylresorcinols are incorporated into human erythrocyte membranes. Br. J. Nutr. 92, 1-4.
57. Linko, A.-M., K.S. Juntunen, H.M. Mykkänen and H. Adlercreutz, 2005. Whole grain rye bread consumption correlates with plasma alkylresorcinols and increases their concentration compared to white wheat bread. J. Nutr. 135, 580-583.
58. Linko, A.-M., A.B. Ross, A. Kamal-Eldin, A. Serena, A.K. Bjørnbak Kjaer, H. Jørgensen, J.L. Penalvo, H. Adlercreutz, P. Åman and K.-E. Bach Knudsen, 2006. Kinetics of the appearance of cereal alkylresorcinols in pig plasma. Brit. J. Nutr. 95, 282-287.
59. Linseisen, J., R. Piller, S. Hermann and J. Chang-Claude, 2004. Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int. J. Cancer 110, 284-290.
60. Liu, S.M., M.J. Stampfer, F.B. Hu, E. Giovannucci, E. Rimm, J.E. Manson, C.H. Hennekens and W.C. Willett, 1999. Whole-grain consumption and risk of coronary heart disease:results from the Nurses' Health Study. Am. J. Clin. Nutr. 70, 412-419.
61. Mazur, W., 1998. Phytoestrogen content in foods. In: H. Adlercreutz (ed.) Phytoestrogens, Vol. 12/Number 4. Baillière's Clinical Endocrinology and Metabolism. London. Baillière Tindall, pp. 729-742.
62. Mazur, W. and H. Adlercreutz, 1998. Natural and anthropogenic environmental oestrogens:the scientific basis for risk assessment. Naturally occurring oestrogens in food. Pure & Appl. Chem. 70, 1759-1776.
63. Mazur, W.M., J.A. Duke, K. Wähälä, S. Rasku and H. Adlercreutz, 1998b. Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. J. Nutr. Biochem. 9, 193-200.
64. Mazur, W., M. Uehara, K. Wähälä and H. Adlercreutz, 1998c. Phytoestrogens in berries -plasma and urine enterolactone concentrations after a single strawberry meal. Brit. J. Nutr. 83, 381-387.
65. Mazur, W.M., K. Wähälä, S. Rasku, A. Salakka, T. Hase and H. Adlercreutz, 1998a. Lignan and isoflavonoid concentrations in tea and coffee. Br. J. Nutr. 79, 37-45.
66. McCann, S.E., C.B. Ambrosone, K.B. Moysich, J. Brasure, J.R. Marshall, J.L. Freudenheim, G.S. Wilkinson and S. Graham, 2005. Intakes of selected nutrients, food, and phytochemicals and prostate cancer risk in western New York. Nutr. Cancer 53, 33-41.
67. McCann, S.E., K.B. Moysich, J.L. Freudenheim, C.B. Ambrosone and P.G. Shields, 2002. The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J. Nutr. 132, 3036-3041.
68. McCann, S.E., P. Muti, D. Vito, S.B. Edge, M. Trevisan and J.L. Freudenheim, 2004. Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int. J. Cancer 111, 440-443.
69. Milder, I.E.J., I.C.W. Arts, B. van de Putte, D.P. Venema and P.C.H. Hollman, 2005. Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Brit. J. Nutr. 93, 393-402.
70. Milder, I.E.J., E.J.M. Feskens, I.C.W. Arts, H.B. Bueno-de-Mesquita, P.C.H. Hollman and D. Kromhout, 2006. Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen elderly study. Am. J. Clin. Nutr. 84, 400-405.
71. Monroe, K.R., S.P. Murphy, B.E. Henderson, L.N. Kolonel, F.Z. Stanczyk, H. Adlercreutz and M.C. Pike, 2004. Dietary fiber intake and serum hormone levels in postmenopausal Mexican American women: the multiethnic cohort study. In Abstracts of the 3rd Annual AACR International Conference: Frontiers in Cancer Prevention Research. Oct 16-20, 2004, Vol. 13. p. 1853s. Cancer Epidemiol. Biomark. Prev. Seattle, Washington, USA.
72. Mutanen, M., A.-M. Pajari and S.I. Oikarinen, 2000. Beef induces and rye bran prevents the formation of intestinal polyps in ApcMin mice: relation to ß-catenin and PKC isozymes. Carcinogenesis 21, 1167-1173.
73. Nishibe, S., 1994. Bioactive lignans and flavonoids from traditional medicines. In: R. Brouillard, M. Jay and A. Scalbert (eds.) 17th Int. Conf. on Polyphenols pp. 113-122. INRA Editions: Palma de Mallorca (Spain).
74. Oikarinen, S., S.M. Heinonen, T. Nurmi, H. Adlercreutz and M. Mutanen, 2005. No effect on adenoma formation in Min mice after moderate amount of flaxseed. Eur. J. Nutr. 44, 273-280.
75. Oikarinen, S.I., A.-M. Pajari and M. Mutanen, 2000. Chemopreventive activity of crude hydroxymatairesinol (HMR) extract in ApcMin mice. Cancer Lett. 161, 253.258.
76. Olsen, A., K.E. Knudsen, B.L. Thomsen, S. Loft, C. Stripp, K. Overvad, S. Möller and A. Tjönneland, 2004. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol. Biomark. Prev. 13, 2084-2089.
77. Parikka, K., I.R. Rowland, R.W. Welch and K. Wähälä, 2006. In vitro antioxidant activity and antigenotoxicity of 5-n-alkylresorcinols. J. Agric. Food Chem. 54, 1646-1650.
78. Park, Y., D.J. Hunter, D. Spiegelman, L. Bergkvist, F. Berrino, P.A. van den Brandt, J.E. Buring, G.A. Colditz, J.L. Freudenheim, C.S. Fuchs, E. Giovannucci, R.A. Goldbohm, S. Graham, L. Harnack, A.M. Hartman, D.R. Jacobs Jr., I. Kato, V. Krogh, M.F. Leitzmann, M.L. McCullough, A.B. Miller, P. Pietinen, T.E. Rohan, A. Schatzkin, W.C. Willett, A. Wolk, A. Zeleniuch-Jacquotte, S.M. Zhang and S.A. Smith-Warner, 2005. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 294, 2849-2857.
79. Pelucchi, C., R. Talamini, C. Galeone, E. Negri, S. Franceschi, L. Dal Maso, M. Montella, E. Conti and C. La Vecchia, 2004. Fibre intake and prostate cancer risk. Int. J. Cancer 109, 278-280.
80. Penalvo, J.L., K.M. Haajanen, N.P. Botting and H. Adlercreutz, 2005b. Quantification of lignan in food using isotope dilution gas chromatography-mass spectrometry. J. Agric. Food Chem. 53, 9342-9347.
81. Penalvo, J.L., S.M. Heinonen, A.M. Aura and H. Adlercreutz, 2005a. Dietary sesamin is converted to enterolactone in humans. J. Nutr. 135, 1056-1062.
82. Pietinen, P., E.B. Rimm, P. Korhonen, A.M. Hartman, W.C. Willett, D. Albanes and J. Virtamo, 1996. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: the alpha-tocopherol, beta-carotene cancer prevention study. Circulation 94, 2720-2727.
83. Pietinen, P., K. Stumpf, S. Männistö, V. Kataja and H. Adlercreutz, 2001. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidem.Biomark. Prev. 70, 339-344.
84. Piller, R., E. Verla-Tebit, S. Wang-Gohrke, J. Linseisen and J. Chang-Claude, 2006. CYP17 genotypes modifies the association between lignan supply and premenopausal breast cancer risk in humans. J. Nutr. 136, 1596-1603.
85. Rimm, E.B., A. Ascherio, E. Giovannucci, D. Spiegelman, M.J. Stampfer and W.C. Willett, 1996. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 275, 447-451.
86. Ross, A.B., W. Becker, Y. Chen, A. Kamal-Eldin and P. Åman, 2005. Intake of alkyl-resorcinols from wheat and rye in the United Kingdom and Sweden. Brit. J. Nutr. 94, 496-499.
87. Ross, A.B., A. Kamal-Eldin and P. Åman, 2004. Dietary alkylresorcinols: Absorption, bioactivities, and possible use as biomarkers of whole-grain wheat- and rye-rich foods. Nutr. Rev. 62, 81-95.
88. Ross, A.B., M.J. Shepherd, M. Schupphaus, V. Sinclair, B. Alfaro, A. Kamal-Eldin and P. Aman, 2003. Alkylresorcinols in cereals and cereal products. J. Agr. Food Chem. 51, 4111-4118.
89. Saarinen, N.M., R. Huovinen, A. Warri, S.I. Mäkelä, L. Valentin-Blasini, R. Sjöholm, J. Ämmälä, R. Lehtilä, C. Eckerman, Y.U. Collan and R.S. Santti, 2002. Enterolactone inhibits the growth of 7,12-dimethylbenz(A) anthracene-induced mammary carcinomas in the rat. Mol. Cancer Ther. 1, 869-876.
90. Saarinen, N.M., A. Wärri, S.I. Mäkelä, C. Eckerman, M. Reunanen, M. Ahotupa, S.M. Salmi, A.A. Franke, L. Kangas and R. Santti, 2000. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr. Cancer 36, 207-216.
91. Seitz, L.M., 1992. Identification of 5-(2-oxoalkyl)resorcinols and 5-(2-oxoalkenyl)resorcinols in wheat and rye grains. J. Agric. Food Chem. 40, 1541-1546.
92. Setchell, K.D.R. and H. Adlercreutz, 1979. The excretion of two new phenolic compounds (180/442 and 180/410) during the human menstrual cycle and in pregnancy. J. Steroid Biochem. 11, xv-xvi.
93. Setchell, K.D.R., A.M. Lawson, F.L. Mitchell, H. Adlercreutz, D.N. Kirk and M. Axelson, 1980a. Lignans in man and in animal species. Nature 287, 740-742.
94. Setchell, K.D.R., R. Bull and H. Adlercreutz, 1980b. Steroid excretion during the reproductive cycle and in pregnancy of the vervet monkey (Ceropithecus aethiopus pygerethus). J. Steroid Biochem. 12, 375-384.
95. Setchell, K.D.R., A.M. Lawson, S.P. Borriello, R. Harkness, H. Gordon, D.M.L. Morgan, D.N. Kirk, H. Adlercreutz, L.C. Anderson and M. Axelson, 1981. Lignan formation in man- microbial involvement and possible roles in relation to cancer. Lancet 2, 4-7.
96. Sih, C.J., P.R. Ravikumar, F.C. Huang, C. Buckner and H. Whitlock, Jr.,1976. Letter:Isolation and synthesis of pinoresinol diglucoside, a major antihypertensive principle of Tu-Chung(Eucommia ulmoides, Oliver). J. Am. Chem. Soc. 98, 5412-5413.
97. Stattin, P., H. Adlercreutz, L. Tenkanen, E. Jellum, S. Lumme, G. Hallmans, S. Harvei, L. Teppo, K. Stumpf, T. Luostarinen, M. Lehtinen, J. Dillner and M. Hakama, 2002. Circulating enterolactone and prostate cancer risk: A Nordic nested case-control. Int. J. Cancer. 99, 124-129.
98. Stattin, P., A. Bylund, C. Biessy, R. Kaaks, G. Hallmans and H. Adlercreutz, 2004. Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control 15, 1095-2004.
99. Stitch, S.R., J.K. Toumba, M.B. Groen, C.W. Funke, J. Leemhuis, J. Vink and G.F.Woods, 1980. Excretion, isolation and structure of a phenolic constituent of female urine. Nature 287, 738-740.
100. Stumpf, K., 2004. Serum enterolactone as a biological marker and in breast cancer: From laboratory to epidemiological studies. In Ph.D. Thesis, University of Helsinki pp. 157,
101. Helsinki. Finland Stumpf, K., M. Uehara, T. Nurmi and H. Adlercreutz, 2000. Changes in the time-resolved fluoroimmunoassay of plasma enterolactone. Anal. Biochem. 284, 153-157.
102. Thompson, L.U., 1998. Experimental studies on lignans and cancer. In: Adlercreutz, H. (editor), Bailliere's Clin Endocrinol Met, Vol. 12. 24-28 Oval Rd, London NW1 7DX, England. BailliereTindall, pp. 691-705.
103. Todd, S., M. Woodward, H. Tunstall-Pedoe and C.Bolton-Smith, 1999. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality:Results from the Scottish Heart Health Study. Am. J. Epidemiol. 150, 1073-1080.
104. Van Kranen, H.J., A. Mortensen, I.K. Sörensen, J. van den Berg-Wijnands, R. Beems, T. Nurmi, H. Adlercreutz and C.F. van Kreijl, 2003. Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in Apc(Min) mice. Nutr. Cancer 45, 203-210.
105. Vanharanta, M., S. Voutilainen, T.A. Lakka, M. van der Lee, H. Adlercreutz and J.T. Salonen, 1999. Risk of acute coronary events according to serum concentrations of enterolactone:a prospective population-based case-control study. Lancet 354, 2112-2115.
106. Vanharanta, M., S. Voutilainen, T.H. Rissanen, H. Adlercreutz and J.T. Salonen, 2003. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone - Kuopio ischaemic heart disease risk factor study. Arch. Intern. Med. 163, 1099-1104.
107. Wang, L.Q., M.R. Meselhy, Y. Li, G.W. Qin and M. Hattori, M., 2000. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem. Pharm. Bull. Tokyo 48, 1606-1610.
108. Wolk, A., J.E. Manson, M.J. Stampfer, G.A. Colditz, F.B. Hu, F.E. Speizer, C.H. Hennekens and W.C. Willett, 1999. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 281, 1998-2004.
109. Xie, L.H., E.M. Ahn, T. Akao, A.A.M. Abdel Hafez, N. Nakamura and M. Hattori, 2003a. Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria. Chem. Pharm. Bull. Tokyo 51, 378-384.
110. Xie, L.H., T. Akao, K. Hamasaki, T. Deyama and M. Hattori, 2003b. Biotransformation of pinoresinol diglucoside to mammalian lignans by human intestinal microflora, and isolation of Enterococcus faecalis strain PDG-1 responsible for the transformation of (+)-pinoresinol to (+)-lariciresinol. Chem. Pharm. Bull. Tokyo 51, 508-515.
111. Zeleniuch-Jacquotte, A., H. Adlercreutz, R.E. Shore, K.L. Koenig, I. Kato, A. Arslan and P. Toniolo, 2004. Circulating enterolactone and risk of breast cancer: a prospective study in New York. Brit. J. Cancer 91, 99-105.